Angle Share Price (AGL)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Angle Plc	LSE:AGL	London	Ordinary Share	GB0034330679	ORD 10P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	0.50	0.76%	66.50	396,194	11:11:37

Bid Price		Offer Price	High Price	Low Price	Open Price
65.00		68.00	66.50	66.00	66.00

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Support Services	0.63	-8.93	-10.09		95.0

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
17:12:49	O	68,116	66.50	GBX

Related Shares
Experian (EXPN), Ferguson (FERG), Phsc (PHSC), Nakama (NAK)

Angle (AGL) Latest News (3)

Angle News

Date	Time	Source	Headline
16/7/2019	16:08	ALNC	Conifer Management Builds 7% Holding In Diagnostics Firm Angle
16/7/2019	09:23	ALNCF	Alliance News Flash Headline
16/7/2019	09:19	UKREG	Angle PLC Holding(s) in Company
12/7/2019	10:22	UKREG	Angle PLC Result of General Meeting anf Total Voting Rights
28/6/2019	13:37	UKREG	Angle PLC Notice of Preliminary Results and Webcast
28/6/2019	13:08	UKREG	Angle PLC Holding(s) in Company
25/6/2019	18:03	ALNC	UPDATE: Angle Placing Raises GBP18 Million For Product Development
25/6/2019	17:19	UKREG	Angle PLC Result of Placing
25/6/2019	13:28	ALNC	Angle To Raise GBP18 Million For Product Development And Partnerships
25/6/2019	08:02	UKREG	Angle PLC Accelerated bookbuild to raise £18.0m

More Angle News

Angle Takeover Rumours

Angle (AGL) Share Charts

1 Year Angle Chart

1 Month Angle Chart

Intraday Angle Chart

Angle (AGL) Discussions and Chat

Angle Forums and Chat

Date	Time	Title	Posts
16/7/2019	18:11	ANGLE PLC - 2019 THREAD - LIQUID BIOPSY COMPANY	1,102
28/2/2019	12:22	ANGLE 2016 – LIQUID BIOPSY TAKEOVER TARGET	11,356
28/8/2018	12:29	ANGLE plc (AGL) One to Watch	-
02/7/2018	12:06	Still time to look at Angle (AGL)	-
14/5/2018	09:44	ANGLE (AGL) Strategic Move	-

Add a New Thread

Angle (AGL) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
16:12:49	66.50	68,116	45,297.14	O
15:28:41	66.00	3,000	1,980.00	O
14:15:50	68.00	714	485.52	O
14:09:00	67.55	4,426	2,989.76	O
14:08:10	67.55	4,426	2,989.76	O

View all Angle trades in real-time

Angle (AGL) Top Chat Posts

Date	Subject
16/7/2019 09:20	Angle Daily Update: Angle Plc is listed in the Support Services sector of the London Stock Exchange with ticker AGL. The last closing price for Angle was 66p. Angle Plc has a 4 week average price of 54.50p and a 12 week average price of 54.50p. The 1 year high share price is 85.50p while the 1 year low share price is currently 38p. There are currently 143,486,522 shares in issue and the average daily traded volume is 249,990 shares. The market capitalisation of Angle Plc is £95,418,537.13. Read Full Thread Reply
12/6/2019 11:11	bones698: Waterloo "just think it's a volume seller " That's quite the statement with no evidence . To wipe millions off the market cap the must be selling 10%of the company shares to create such a drop and also be no buyers of the shares too. Whilst there may well be a seller they tend to sell for a reason and I stick with my theory that a funding is being readied and that is creating the negative impact on the share price . Time will tell but I'm usually on the money as people have seen before . If the share price levels off then you may be right but I see no signs of that happening ATM so stick with my theory for now Read Full Thread Follow Reply
06/6/2019 08:50	jelenko: NY Boy. It all depends on why people invest here. Most of our families have been touched by the horrible illness that AGL are targeting and that may have some influence. Clearly we believe our investments will grow at the same time. I see that STX has had a good run in the lead up to FDA decision. It is likely that AGL will do the same although not guaranteed. STX are involved in the medication side which is different of course to AGL's non invasive liquid biopsy. We don't have side effect issues etc. The constant stream of good results and praise by the present research use users gives me confidence that we will obtain FDA within the next 6-8 months. This is not very long in the scheme of things, we have waited patiently for a number of years already. The prospect of a share price at circa £2.50 in January (if we follow STX uplift profile)is also appealing. Read Full Thread Follow Reply
06/5/2019 15:59	alloa2003: I think the AGL share price is starting to reflect the potential value based on the risk that it may or may not be realised. For example if the potential value was £2 a share (based on profit, pe ratio, etc) and the chance of being successful was deemed 80% then you would expect the price to be much closer to £2. It is a form of arbitration with the share price reflecting the risk/reward factor compared to potential "fair value". Read Full Thread Follow Reply
22/4/2019 23:29	sicilian_kan: If the MBC trial is not, on the existing data (however confident one is) a nailed on certainty, surely the next questions are: 1) What is the best estimate probability of commercial data appearing in the MBC trial? 2) What share price spectrum might arise if the trial demonstrates commercial data? 3) What share price spectrum might arise if the trial does not demonstrate commercial data? Then an investment strategy can be formulated. There is far too little analysis of the actual MBC data that is available. There is also far too little analysis on here of the chance of success and on the share price gains and falls that might occur upon the MBC trial data being released. Read Full Thread Follow Reply
18/4/2019 09:00	alloa2003: There has been a sea change in the AGL share price of late, no highs then sharp reversals on announcements and no drifting on a lack of news. There is strong underlying demand for the shares which leads me to believe things are afoot behind the scenes. Read Full Thread Follow Reply
10/4/2019 09:46	sicilian_kan: At 70p, AGL's fully diluted market cap is £126m. 143,486,522 shares in issue, plus 20,555,806 options etc. = 164,042,328 shares fully diluted. This might see a 75p top before news, but quite frankly, the current share price is way overvalued given the risk involved, the laborious process involved (see youtube video) and the likely revenues from MBC. Given the hype around AGL, I think on good news 100-150p could be hit. On bad MBC results, we are looking at 10p-35p depending on how bad the results are. Results could also be mixed. So short term upside of 50-100%, short term downside potential of 50-80%. Chance of success, say 80-85%? I bear in mind that the ovarian trial was disappointing relative to the earlier study results. With significant downside possibility, I would expect a risk reward ratio of at least 3:1 to make this attractive. Fair price circa 50-55p? For those in at that level, it is definitely worth a hold, but I do not see buying in at the current share price as being in any way attractive. Read Full Thread Follow Reply
29/1/2019 10:20	semper vigilans: As usual a decent bit of research from a large, highly reputable organisation working in the right field, is not really recognised by the market. Whatever one thinks of false starts earlier, at some stage the build up of published, independent research must give the AGL share price a decent, upward shove? Read Full Thread Follow Reply
06/12/2018 10:46	alloa2003: Brexit is not helping sentiment but not the reason for AGL share price weakness. There is literally no interest in the stock at the moment - going to be news driven for some time to come until we see sales and profits. Might drift until it finds support. Read Full Thread Follow Reply
26/3/2018 09:17	alloa2003: I think AGL share price suffers from boredom at times between announcements. Very news driven as profitability is some way off. Read Full Thread Follow Reply
24/12/2017 11:06	alloa2003: Its that time of year - what are your predicitons for the AGL share price in 12 months? I will start at £2 a share :) Read Full Thread Follow Reply

Angle share price data is direct from the London Stock Exchange

Your Recent History

LSE

AGL

Angle

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P: V: D:20190716 17:14:13